Breaking News Instant updates and real-time market news.

APTO

Aptose Biosciences

$2.02

-0.06 (-2.88%)

16:07
01/24/19
01/24
16:07
01/24/19
16:07

Aptose Biosciences initiated with an Outperform at Oppenheimer

Oppenheimer initiated Aptose Biosciences with an Outperform and $6 price target.

APTO Aptose Biosciences
$2.02

-0.06 (-2.88%)

11/16/18
RILY
11/16/18
INITIATION
Target $5
RILY
Buy
Aptose Biosciences initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Dylan Dupuis started Aptose Biosciences with a Buy rating and $5 price target citing the potential of the company's "two unique first-in-class "drugs entering the clinic to treat different kinds of leukemia. The analyst sees potential for an accelerated path to market for CG-806 to treat acute myelogenous leukemia based on "strong preclinical efficacy and safety data."
10/10/18
HCWC
10/10/18
NO CHANGE
Target $8.5
HCWC
Buy
Aptose Biosciences recent selloff unwarranted, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis attributes the recent weakness in shares of Aptose Biosciences to the pushout of the CG-806 investigational new drug application from year-end 2018 to early 2019 as well as the planned addition of a healthy volunteer pharmacokinetic study for the AML arm of the planned IND. The analyst believes some investors have wrongly associated this with potential issues regarding the ongoing toxicology studies. He views the pullback as warranted and thinks current share levels of Aptose represent a "compelling opportunity to participate in a ground floor opportunity of two potential transformational drugs." Pantginis reiterates a Buy rating on the shares with an $8.50 price target.
06/29/18
HCWC
06/29/18
NO CHANGE
Target $8.5
HCWC
Buy
Aptose Biosciences target raised to $8.50 at H.C. Wainwright after hold lifted
H.C. Wainwright analyst Joseph Pantginis raised his price target on Aptose Biosciences to $8.50 from $6.00 after the FDA lifted the clinical hold on APTO-253, stating that he believes the company has two potentially first-in and best-in class drugs for the treatment of hematological malignancies with that one and CG-806. He maintains a Buy rating on Aptose Biosciences shares, which are up 17c, or 4.5%, to $3.95 in early trading.
06/15/18
HCWC
06/15/18
NO CHANGE
Target $6
HCWC
Buy
Aptose presentation at EHA strengthens profile for CG-806, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis said the presentation made today at the EHA meeting by Aptose Biosciences strengthens the profile for CG-806 and his confidence is higher that the preclinical database generated should translate to meaningful clinical responses in AML and lymphoma patients. He maintains a Buy rating and $6 price target on Aptose shares.

TODAY'S FREE FLY STORIES

PVTL

Pivotal Software

$19.94

-0.02 (-0.10%)

15:36
03/20/19
03/20
15:36
03/20/19
15:36
Options
Calls lead puts 25:1 in Pivotal Software »

Calls lead puts 25:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

SYX

Systemax

$21.53

0.23 (1.08%)

15:35
03/20/19
03/20
15:35
03/20/19
15:35
Conference/Events
Systemax management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 28

    Mar

WSM

Williams-Sonoma

$57.40

0.61 (1.07%)

15:34
03/20/19
03/20
15:34
03/20/19
15:34
Options
Williams Sonoma options imply 10.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

SCS

Steelcase

$15.43

-2.055 (-11.75%)

15:34
03/20/19
03/20
15:34
03/20/19
15:34
Conference/Events
Steelcase management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 25

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

15:30
03/20/19
03/20
15:30
03/20/19
15:30
General news
Powell on the maturity distribution of the portfolio: »

Powell on the maturity…

VLKAY

Volkswagen

$0.00

(0.00%)

15:25
03/20/19
03/20
15:25
03/20/19
15:25
Periodicals
Volkswagen management not yet aligned on restructuring plans, Reuters says »

Volkswagen's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
03/20/19
03/20
15:20
03/20/19
15:20
General news
Powell on the balance sheet: »

Powell on the balance…

15:20
03/20/19
03/20
15:20
03/20/19
15:20
General news
Powell on Brexit »

Powell on Brexit: he hope…

WPM

Wheaton Precious Metals

$23.12

0.385 (1.69%)

15:19
03/20/19
03/20
15:19
03/20/19
15:19
Options
Wheaton Precious Metals options imply 6.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
03/20/19
03/20
15:17
03/20/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
03/20/19
03/20
15:16
03/20/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
03/20/19
03/20
15:15
03/20/19
15:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

AMZN

Amazon.com

$1,793.67

31.22 (1.77%)

15:11
03/20/19
03/20
15:11
03/20/19
15:11
Hot Stocks
Amazon.com announces launch of MLB.TV on Prime Video Channels »

Amazon announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

UNIT

Uniti Group

$9.94

0.08 (0.81%)

15:04
03/20/19
03/20
15:04
03/20/19
15:04
Options
Uniti Group options imply 6.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVS

Novartis

$93.75

0.76 (0.82%)

15:01
03/20/19
03/20
15:01
03/20/19
15:01
Periodicals
Novartis CEO wants to move towards 'transformational innovation,' Fortune says »

Novartis CEO Vasant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.06

0.58 (0.21%)

15:00
03/20/19
03/20
15:00
03/20/19
15:00
General news
Fed chair Powell says he thinks 'deficits matter' »

Federal Reserve chairman…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.06

0.58 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
03/20/19
03/20
15:00
03/20/19
15:00
General news
FX Action: USD-CAD »

FX Action: USD-CAD hit…

14:55
03/20/19
03/20
14:55
03/20/19
14:55
General news
Canada wholesale report preview »

Canada wholesale report…

14:55
03/20/19
03/20
14:55
03/20/19
14:55
General news
Fed Chairman Powell on the outlook: »

Fed Chairman Powell on…

14:55
03/20/19
03/20
14:55
03/20/19
14:55
General news
Powell on the balance of risks: »

Powell on the balance of…

BA

Boeing

$379.38

5.51 (1.47%)

, LMT

Lockheed Martin

$298.16

1.61 (0.54%)

14:52
03/20/19
03/20
14:52
03/20/19
14:52
Periodicals
Pentagon's IG investigating Shanahan over Boeing comments, Politico says »

The Pentagon's…

BA

Boeing

$379.38

5.51 (1.47%)

LMT

Lockheed Martin

$298.16

1.61 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.17

0.69 (0.24%)

14:52
03/20/19
03/20
14:52
03/20/19
14:52
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Fed chair Powell says…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.17

0.69 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$88.99

-0.11 (-0.12%)

14:50
03/20/19
03/20
14:50
03/20/19
14:50
Options
Bullish three-way spread in Celgene »

Bullish three-way spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Apr

  • 18

    May

  • 28

    May

  • 27

    Jun

  • 03

    Sep

ALXN

Alexion

$132.07

-0.87 (-0.65%)

14:49
03/20/19
03/20
14:49
03/20/19
14:49
Recommendations
Alexion analyst commentary at Piper Jaffray »

Alexion turnaround…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.24

0.76 (0.27%)

14:49
03/20/19
03/20
14:49
03/20/19
14:49
General news
Fed chair Powell says ongoing risks to outlook include Brexit, trade talks »

Federal Reserve chairman…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.24

0.76 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.